- Home
- MRKR vs AACG Comparison
MRKR vs AACG Comparison
Compare MRKR & AACG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRKR
- AACG
- Stock Information
- Founded
- MRKR N/A
- AACG 1999
- Country
- MRKR United States
- AACG China
- Employees
- MRKR N/A
- AACG N/A
- Industry
- MRKR Biotechnology: Pharmaceutical Preparations
- AACG Other Consumer Services
- Sector
- MRKR Health Care
- AACG Real Estate
- Exchange
- MRKR Nasdaq
- AACG Nasdaq
- Market Cap
- MRKR 35.8M
- AACG 31.9M
- IPO Year
- MRKR N/A
- AACG N/A
- Fundamental
- Price
- MRKR $3.50
- AACG $1.02
- Analyst Decision
- MRKR Strong Buy
- AACG
- Analyst Count
- MRKR 1
- AACG 0
- Target Price
- MRKR $19.00
- AACG N/A
- AVG Volume (30 Days)
- MRKR 34.9K
- AACG 57.6K
- Earning Date
- MRKR 11-22-2024
- AACG 11-07-2024
- Dividend Yield
- MRKR N/A
- AACG N/A
- EPS Growth
- MRKR N/A
- AACG N/A
- EPS
- MRKR N/A
- AACG N/A
- Revenue
- MRKR $3,727,435.00
- AACG $35,747,843.00
- Revenue This Year
- MRKR $35.94
- AACG N/A
- Revenue Next Year
- MRKR N/A
- AACG N/A
- P/E Ratio
- MRKR N/A
- AACG N/A
- Revenue Growth
- MRKR N/A
- AACG 15.80
- 52 Week Low
- MRKR $2.44
- AACG $0.50
- 52 Week High
- MRKR $6.16
- AACG $1.65
- Technical
- Relative Strength Index (RSI)
- MRKR 46.47
- AACG 58.61
- Support Level
- MRKR $3.52
- AACG $0.98
- Resistance Level
- MRKR $3.90
- AACG $1.06
- Average True Range (ATR)
- MRKR 0.40
- AACG 0.06
- MACD
- MRKR -0.08
- AACG -0.01
- Stochastic Oscillator
- MRKR 0.00
- AACG 66.67
About MRKR Marker Therapeutics Inc.
Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and innovative peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets. It is also developing peptide-based immunotherapeutic vaccines for the treatment of metastatic solid tumors, as well as PolyStart.
About AACG ATA Creativity Global
ATA Creativity Global is an international educational services company focused on providing quality learning experiences that cultivate and enhance students' creativity. The operating segments are Overseas art study services, Other educational services and K-12 education assessment and other services. Majority of its revenue comes from Overseas art study services.